 |
|
|
| |
SAFETY ANALYSIS OF GERMAN REAL-LIFE COHORT WIP SHOWS
LOW RATES OF NEUROPSYCHIATRIC EVENTS LEADING TO DISCONTINUATION OF RALTEGRAVIR THERAPY
|
| |
| |
Reported by Jules Levin
19th International Workshop on Co-morbidities and Adverse Drug Reactions, Milan, Italy, October 23-25, 2017 and the EACS Conference 2017, Milan, Italy, October 25-27, 2017
U. Naumann1, A. Moll1, D. Schleehauf1, K. Ummard-Berger1, T. Lutz2, W. Schmidt3, H. Jaeger4, B. Funke5, V. Witte5
1Praxiszentrum Kaiserdamm, Berlin, Germany, 2Infektiologikum Frankfurt, Frankfurt, Germany, 3MVZ Arzteforum Seestrasse, Berlin, Germany,
4MVZ Karlsplatz, HIV Research and Clinical Care Centre, Munich, Germany, 5MSD Germany, Medical Affairs, Haar, Germany
|
| |
|
|
|
|
|
